Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Zhong-Yin Zhang1

  • 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. zyzhang@aecom.yu.edu

Annual Review of Pharmacology and Toxicology
|January 25, 2002
PubMed
Summary

Protein tyrosine phosphatases (PTPs) are key enzymes in cell signaling, and their dysfunction causes human disorders. This review explores PTP structure-function, substrate recognition, and the development of targeted PTP inhibitors for drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity.

Journal of medicinal chemistry·2026
Same author

Dehydration/1,6-addition-based Site-specific Bioconjugation Unveils Norepinephrinylation as a Widespread Post-translational Modification in the Cellular Proteome.

bioRxiv : the preprint server for biology·2026
Same author

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same author

[The Influencing Factors of Platelet Transfusion Efficacy in Hematological Disease Chemotherapy Patients and the Construction and Validation of a Nomogram Risk Prediction Model].

Zhongguo shi yan xue ye xue za zhi·2026
Same author

Design, synthesis, and in-vitro evaluation of 2-(heteroarylthio)acetamido-1<i>H</i>-benzo[<i>d</i>]imidazole derivatives as PTP1B inhibitors for the treatment of type 2 diabetes.

3 Biotech·2026
Same author

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

Blood advances·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Protein tyrosine phosphatases (PTPs) are crucial signaling enzymes regulating cellular processes.
  • PTP malfunction is linked to various human diseases, highlighting their therapeutic potential.
  • Existing structural and substrate specificity data offer a basis for rational drug design targeting PTPs.

Purpose of the Study:

  • To review the correlation between PTP structure and function based on mutagenesis studies.
  • To elucidate the molecular mechanisms of substrate recognition for PTP1B and MKP3.
  • To present strategies for developing specific and high-affinity PTP inhibitors.

Main Methods:

  • Analysis of mutagenesis experiments to understand PTP structure-function relationships.

Related Experiment Videos

  • Discussion of molecular determinants for PTP1B and MKP3 substrate binding.
  • Review of recent advances in designing PTP inhibitors.

    • Main Results:

    • Mutagenesis studies reveal key structure-function correlations in PTPs.
    • Insights into the molecular basis of substrate recognition for PTP1B and MKP3.
    • A strategy for developing bidentate inhibitors targeting both the active and adjacent sites of PTPs.

    Conclusions:

    • PTPs represent a promising drug discovery target due to their roles in cellular signaling and disease.
    • Understanding PTP structure and substrate specificity is vital for designing effective inhibitors.
    • Novel inhibitor strategies, including bidentate approaches, show potential for developing potent and selective PTP therapeutics.